Prevalence and control rates of hypertension in the USA: 2017-2018.
Prevalence and control rates of hypertension in the USA: 2017-2018.
复制标题
DOI:
10.1016/j.ijchy.2020.100044
复制
发表时间:
2020-09
期刊:
影响因子:
--
通讯作者:
Nfor T
中科院分区:
文献类型:
--
作者:
Chobufo MD;Gayam V;Soluny J;Rahman EU;Enoru S;Foryoung JB;Agbor VN;Dufresne A;Nfor T
Recent review of hypertension guidelines requires fresh updates of prevalence and control rates. Though retrospective analysis provided burden estimates, control rates were grossly misleading. We set out to update the prevalence and control rates of hypertension in the USA using contemporary NHANES data. Persons with mean systolic blood pressure (mSBP) ≥130 mmHg or mean diastolic blood pressure (mDBP) ≥80 mmHg or self-reported current use of antihypertensive medications were classified as hypertensives. Hypertensives on medications with mSBP <130 mmHg and mDBP <80 mmHg were classified as having well-controlled hypertension. Subgroup comparisons of hypertension prevalence were computed using Chi-square test. Predictors of hypertension and well-controlled BP were assessed using multivariable logistic regressions. Two tailed p-values <0.05 were considered statistically significant. The prevalence of hypertension in the USA in 2017–2018 was 49.64% (95% CI 46.67–52.61) corresponding to 115(95% CI 104–128) million persons. NH Blacks: 58.53% (95% CI 55.39–61.60); Men: 54.46% (95% CI 51.01–57.87); older persons and obese individuals: 61.03% (95% CI 57.31–64.63) as well as persons with diabetes and CKD, comparatively. The overall rate of well-controlled hypertension was 39.64% (95% CI 36.20–42.81). Persons with at least a college degree: OR 2.20(95% CI 1.02–5.04, p=0.049) and persons with incomes ≥3 times the poverty threshold; OR 1.88(95% CI 1.1.8–2.99, p=0.011) had higher rates of well-controlled hypertension when compared to lowest categories. One in every two persons ≥20 years in the USA has hypertension with only 39.64% on medications having well-controlled hypertension. Significant discrepancies exist in the burden and control rates in different subpopulation categories. Targeted interventions could help improve the prevalence and hypertension control rates in the USA.
登录
查看更多内容
影响因子:
39.2
作者:
Levey AS;Stevens LA;Schmid CH;Zhang YL;Castro AF 3rd;Feldman HI;Kusek JW;Eggers P;Van Lente F;Greene T;Coresh J;CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
通讯作者:
CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
影响因子:
3.5
作者:
Ditah, Chobufo Muchi;Rahman, Ebad;Dufresne, Alix
通讯作者:
Dufresne, Alix
DOI:
10.1056/nejmoa1511939
发表时间:
2015-11-26
期刊:
The New England journal of medicine
影响因子:
--
作者:
SPRINT Research Group;Wright JT Jr;Williamson JD;Whelton PK;Snyder JK;Sink KM;Rocco MV;Reboussin DM;Rahman M;Oparil S;Lewis CE;Kimmel PL;Johnson KC;Goff DC Jr;Fine LJ;Cutler JA;Cushman WC;Cheung AK;Ambrosius WT
通讯作者:
Ambrosius WT
影响因子:
37.8
作者:
Mills KT;Bundy JD;Kelly TN;Reed JE;Kearney PM;Reynolds K;Chen J;He J
通讯作者:
He J
影响因子:
5.4
作者:
Dorans KS;Mills KT;Liu Y;He J
通讯作者:
He J